Mr. Bush’s Stem Cell Diversion

From Discourse DB
Revision as of 14:17, June 21, 2007 by Yaron Koren (talk | contribs) (New page: {{item |author=The New York Times editorial board |source=The New York Times |date=June 21, 2007 |url=http://www.nytimes.com/2007/06/21/opinion/21thu1.html |quote="Both the Senate and the ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

This is an opinion item.

Author(s) The New York Times editorial board
Source The New York Times
Date June 21, 2007
URL http://www.nytimes.com/2007/06/21/opinion/21thu1.html
Quote
Quotes-start.png "Both the Senate and the House, which passed the embryonic stem cell bill by comfortable but not veto-proof margins, need to summon the strength to override Mr. Bush’s veto, so that important research into possible cures for Parkinson’s, diabetes and other serious ailments can move ahead." Quotes-end.png


Add or change this opinion item's references


This item argues for the position Act should be passed on the topic Stem Cell Research Enhancement Act of 2007.